Prelude Capital Management, LLC Bridge Bio Pharma, Inc. Transaction History
Prelude Capital Management, LLC
- $1.85 Billion
- Q1 2024
A detailed history of Prelude Capital Management, LLC transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Prelude Capital Management, LLC holds 11,514 shares of BBIO stock, worth $286,813. This represents 0.02% of its overall portfolio holdings.
Number of Shares
11,514
Previous 15,254
24.52%
Holding current value
$286,813
Previous $615,000
42.11%
% of portfolio
0.02%
Previous 0.04%
Shares
6 transactions
Others Institutions Holding BBIO
# of Institutions
285Shares Held
170MCall Options Held
7.41MPut Options Held
2.61M-
Kohlberg Kravis Roberts & Co. L.P. New York, NY31.1MShares$774 Million40.56% of portfolio
-
Viking Global Investors LP25.1MShares$626 Million2.96% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.2MShares$329 Million0.01% of portfolio
-
Black Rock Inc. New York, NY10.5MShares$261 Million0.01% of portfolio
-
Aisling Capital Management LP New York, NY6.07MShares$151 Million64.21% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $3.69B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...